CD79A and primary cutaneous T-cell non-Hodgkin lymphoma: We further validated the increased presence of B cells in CTCL skin biopsies using IHC by staining for CD20 and CD79a in three independent CTCL cohorts (n = 56) (Fig. 7b,c).